BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rindi G, Wiedenmann B. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat Rev Endocrinol 2020;16:590-607. [PMID: 32839579 DOI: 10.1038/s41574-020-0391-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Uddin MH, Al-Hallak N, Philip PA, Chen H, El-Rayes B, Azmi AS. Aberrant transcription factors in the cancers of the pancreas. Semin Cancer Biol 2022:S1044-579X(22)00197-3. [PMID: 36058426 DOI: 10.1016/j.semcancer.2022.08.011] [Reference Citation Analysis]
2 Islam R, Mishra J, Polavaram NS, Bhattacharya S, Hong Z, Bodas S, Sharma S, Bouska A, Gilbreath T, Said AM, Smith LM, Teply BA, Muders MH, Batra SK, Datta K, Dutta S. Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance. Cell Rep 2022;40:111097. [PMID: 35858551 DOI: 10.1016/j.celrep.2022.111097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mori N, Hongo M, Takemura S, Sugitani Y, Nakamura F, Tani M, Nishida A, Inatomi O, Andoh A, Ban H. Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5640] [Reference Citation Analysis]
4 Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 2022;33:115-54. [PMID: 35294740 DOI: 10.1007/s12022-022-09708-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
5 Mettler E, Fottner C, Bakhshandeh N, Trenkler A, Kuchen R, Weber MM. Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias. Cancers 2022;14:1025. [DOI: 10.3390/cancers14041025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lamarca A, Frizziero M, Barriuso J, Kapacee Z, Mansoor W, Mcnamara MG, Hubner RA, Valle JW. Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice. Cancers 2022;14:1017. [DOI: 10.3390/cancers14041017] [Reference Citation Analysis]
7 Endo M, Huang EC, Roth MY. Newly Developed Pathologic Grading System Predicts Clinical Outcomes in Medullary Thyroid Carcinoma. Clinical Thyroidology 2022;34:89-91. [DOI: 10.1089/ct.2022;34.89-91] [Reference Citation Analysis]
8 Carpizo DR, Harris CR. Genetic Drivers of Ileal Neuroendocrine Tumors. Cancers (Basel) 2021;13:5070. [PMID: 34680217 DOI: 10.3390/cancers13205070] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Escobar KM, Vicente-villardon JL, de la Hoz-m J, Useche-castro LM, Alarcón Cano DF, Siteneski A. Frequency of Neuroendocrine Tumor Studies: Using Latent Dirichlet Allocation and HJ-Biplot Statistical Methods. Mathematics 2021;9:2281. [DOI: 10.3390/math9182281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Danti G, Flammia F, Matteuzzi B, Cozzi D, Berti V, Grazzini G, Pradella S, Recchia L, Brunese L, Miele V. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging. Radiol Med 2021;126:1497-507. [PMID: 34427861 DOI: 10.1007/s11547-021-01408-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Zhou S, Jiang S, Chen W, Yin H, Dong L, Zhao H, Han S, He X. Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram. Front Oncol 2021;11:654439. [PMID: 34350109 DOI: 10.3389/fonc.2021.654439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Faggiano A, Colao A. Editorial-Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education. Front Endocrinol (Lausanne) 2021;12:722145. [PMID: 34276572 DOI: 10.3389/fendo.2021.722145] [Reference Citation Analysis]
13 Fehrenbach U, Xin S, Hartenstein A, Auer TA, Dräger F, Froböse K, Jann H, Mogl M, Amthauer H, Geisel D, Denecke T, Wiedenmann B, Penzkofer T. Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI-A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making. Cancers (Basel) 2021;13:2726. [PMID: 34072865 DOI: 10.3390/cancers13112726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
15 Simbolo M, Bilotta M, Mafficini A, Luchini C, Furlan D, Inzani F, Petrone G, Bonvissuto D, La Rosa S, Schinzari G, Bianchi A, Rossi E, Menghi R, Giuliante F, Boccia S, Scarpa A, Rindi G. Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades. Cancers (Basel) 2021;13:2054. [PMID: 33922803 DOI: 10.3390/cancers13092054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Alevroudis E, Spei ME, Chatziioannou SN, Tsoli M, Wallin G, Kaltsas G, Daskalakis K. Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:1813. [PMID: 33920195 DOI: 10.3390/cancers13081813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
17 Amarù J, Barbieri F, Arvigo M, Solari A, Bajetto A, Nista F, Campana C, Gaggero G, Prior A, Criminelli Rossi D, Zona G, Ferone D, Florio T, Gatto F. Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects. Cancers (Basel) 2021;13:1816. [PMID: 33920241 DOI: 10.3390/cancers13081816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Inzani F, Rindi G. Introduction to neuroendocrine neoplasms of the digestive system: definition and classification. Pathologica 2021;113:1-4. [PMID: 33686304 DOI: 10.32074/1591-951X-227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]